Skip to main content
. 2022 Jul 4;23:637. doi: 10.1186/s12891-022-05587-0

Table 2.

Patient characteristics at baseline

Variable CTHR (n = 120)
Age (years), No.%
 30 ≤, < 45 45(37.5)
 45 ≤, < 60 75(62.5)
Sex, No. %
 Male 67(55.8)
 Female 53(44.2)
BMI (kg/m2)
 Mean (range) 26.8 (18.3–38.2)
BMD −3.76 ± 0.82
Autogenous iliac bone grafts, No.%
 Yes 63(52.5)
 No 57(47.5)
Type of prior fractures, No.%
 Femoral neck fractures
  Subcapital 12(10.0)
  Transcervical 24(20.0)
  Base neck 19(15.8)
 Intertrochanteric fractures (Evans-Jensen classification)
  Type I 8(6.7)
  Type II 13(10.8)
  Type III 21(17.5)
  Type IV 18(15.0)
  Type V 5(4.2)
Prosthesis types of prior fixation failures, No.%
 PFNAa (femoral neck fractures and intertrochanteric fractures)
  Base neck 19(15.8)
  Type I 2(1.6)
  Type II 3(2.5)
  Type III 10(8.3)
  Type IV 8(6.6)
  Type V 3(2.5)
 Three hollow screwsb (femoral neck fractures)
  Subcapital 12(10.0)
  Transcervical 24(20.0)
 DHSb (intertrochanteric fractures)
  Type I 1(0.8)
  Type II 3(2.5)
  Type III 11(9.1)
  Type IV 10(8.3)
  Type V 2(1.6)
 Titanium platec plus screwsb (intertrochanteric fractures)
  Type I 5(4.2)
  Type II 7(5.8)
Time to conversion (mos), No.%
  < 3 78(65.0)
  ≥ 3 42(35.0)
Femoral head size (mm), No.%
 28 42(35.0)
 32 48(40.0)
 36 30(25.0)
CCI at conversion, No. %
 Low 59(49.2)
 Medium 43(35.8)
 High 18(15.0)
Indications for CTHR revision, No. %
 Instability 66(55.0)
 Mechanical failure 35(29.2)
 Both 19(15.8)
ASA physical status, No.%
 1 35(29.2)
 2 63(52.5)
 3 22(18.3)
HHS prior to conversion 51.5 ± 14.1
Follow-up (years)
 Median (range) 10.2(8–12)

CTHR cemented total hip replacement, BMI body mass index, BMD bone mineral density, PFNA proximal femoral nail antirotation, DHS dynamic hip screw, CCI Charlson comorbidity index, ASA American Society of Anesthesiologists, HHS Harris hip scores

aSmith & Nephew, Memphis, Tennessee

bDouble Medical, Xiamen, China

cSynthes, West Chester, PA, USA